Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

3.50
Delayed Data
As of Aug 16
 -0.15 / -4.11%
Today’s Change
2.00
Today|||52-Week Range
4.55
+16.67%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close3.65
Today’s open3.65
Day’s range3.50 - 3.65
Volume548,998
Average volume (3 months)323,573
Market cap$119.8M
Dividend yield--
Data as of 4:00pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+46.82%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd-0.03-2.61%
AGRXAgile Therapeutics I...-0.06-1.72%
MRTXMirati Therapeutics ...0.000.00%
PRQRProQR Therapeutics N...+0.05+1.02%
Data as of 4:00pm ET, 08/16/2017

Financials

Last reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts